Pharma Aids Limited (DSE:PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 534.60
-2.00 (-0.37%)
At close: Mar 3, 2025
Pharma Aids Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | 62.48 | 61.19 | -6.38 | 34.76 | 50.26 | 52.47 | Upgrade
|
| Depreciation & Amortization | 6.63 | 6.92 | 7.62 | 7.82 | 8.25 | 8.57 | Upgrade
|
| Other Operating Activities | -6.06 | -4.82 | -6.51 | -3.69 | -4.8 | 8.73 | Upgrade
|
| Change in Accounts Receivable | 2.11 | 1.63 | -2.54 | 6.21 | 11.85 | - | Upgrade
|
| Change in Inventory | -56.42 | -17.47 | 6.5 | -15.18 | -27.67 | 11.16 | Upgrade
|
| Change in Accounts Payable | -0.73 | 3.89 | 0.24 | 1.25 | -0.26 | -39.95 | Upgrade
|
| Change in Other Net Operating Assets | -1.6 | -28.55 | 8.33 | 2.67 | -6.22 | -0.3 | Upgrade
|
| Operating Cash Flow | 6.41 | 22.79 | 7.27 | 33.85 | 31.41 | 40.69 | Upgrade
|
| Operating Cash Flow Growth | -78.54% | 213.55% | -78.53% | 7.77% | -22.82% | 62.07% | Upgrade
|
| Capital Expenditures | -2.67 | -0.18 | -2.21 | -4.7 | -10.28 | -5 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.55 | - | - | - | - | 0.3 | Upgrade
|
| Other Investing Activities | 0.11 | 0.11 | 0.2 | 0.37 | 4.6 | -2.9 | Upgrade
|
| Investing Cash Flow | -15.45 | -0.07 | -2.01 | -4.33 | -5.68 | -7.6 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.49 | 0.68 | - | 1.39 | Upgrade
|
| Total Debt Issued | - | - | 0.49 | 0.68 | - | 1.39 | Upgrade
|
| Short-Term Debt Repaid | - | -0.28 | - | - | -4.78 | -16.41 | Upgrade
|
| Total Debt Repaid | -0.28 | -0.28 | - | - | -4.78 | -16.41 | Upgrade
|
| Net Debt Issued (Repaid) | -0.28 | -0.28 | 0.49 | 0.68 | -4.78 | -15.03 | Upgrade
|
| Common Dividends Paid | -3.28 | -4.83 | -15.54 | -25.27 | -15.05 | -18.91 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | 5.15 | Upgrade
|
| Financing Cash Flow | -3.55 | -5.11 | -15.05 | -24.59 | -19.83 | -28.79 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | -12.59 | 17.61 | -9.79 | 4.93 | 5.89 | 4.3 | Upgrade
|
| Free Cash Flow | 3.74 | 22.6 | 5.06 | 29.15 | 21.12 | 35.69 | Upgrade
|
| Free Cash Flow Growth | -86.53% | 346.82% | -82.64% | 37.97% | -40.81% | 53.16% | Upgrade
|
| Free Cash Flow Margin | 0.87% | 5.37% | 1.64% | 9.02% | 7.54% | 13.24% | Upgrade
|
| Free Cash Flow Per Share | 1.20 | 7.24 | 1.62 | 9.34 | 6.77 | 11.44 | Upgrade
|
| Cash Interest Paid | 0.68 | 0.26 | 0.24 | 0.24 | 0.9 | 0.89 | Upgrade
|
| Cash Income Tax Paid | 33.89 | 32.43 | 23.71 | 25.15 | 23.17 | 13.1 | Upgrade
|
| Levered Free Cash Flow | -28.9 | 5.59 | 9.86 | 20.13 | 17.39 | 21.6 | Upgrade
|
| Unlevered Free Cash Flow | -28.47 | 5.75 | 10.01 | 20.37 | 17.95 | 22.16 | Upgrade
|
| Change in Net Working Capital | 86.16 | 53.72 | 2.07 | 16.52 | 21.47 | 26.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.